Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer

2005 ◽  
Author(s):  
Andrea L. Cheville
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Lymph Node ◽  
Lymph Node Dissection ◽  
Primary Breast Cancer ◽  
Node Dissection

scholarly journals Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer

2019 ◽  
Vol 120 (8) ◽  
pp. 1397-1403
Author(s):  
Jolinta Y. Lin ◽  
Xiaofeng Yang ◽  
Monica Serra ◽  
Andrew H. Miller ◽  
Karen D. Godette ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Lymph Node ◽  
Axillary Lymph Node Dissection ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Epidermal Thickness

scholarly journals IMPACT OF THE NUMBER OF DISSECTED AXILLARY LYMPH NODES ON SURVIVAL IN BREAST CANCER PATIENTS

2019 ◽  
Vol 3 (7) ◽  
Author(s):  
Dr. CM Goapl Kesari ◽  
Dr. Sudhakar Kotlapati
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Lymph Node ◽  
Lymph Node Dissection ◽  
Breast Cancer Mortality ◽  
Breast Conservation ◽  
Adjuvant Radiation ◽  
Axillary Lymph ◽  
Breast Irradiation ◽  
Node Dissection

INTRODUCTION: Locoregional control as well as breast cancer mortality benefit have been shown from adjuvant radiation therapy following breast conservation surgery or following mastectomy with node-positive disease. Partial breast irradiation via external brachytherapy, beam, or intraoperative techniques has been shown to limit the volume of irradiated tissue in select groups of women while preserving efficacy although data on long-term outcomes is limited. MATERIAL AND METHODS: Early stage breast cancer (BC) patients with histologically confirmed invasive breast carcinoma clinically 5 cm or less in size, no palpable adenopathy, and with sentinel nodes were included in the study that received lumpectomy with whole-breast irradiation, and underwent either axillary lymph node dissection (ALND) or sentinel lymph node dissection (SLND) alone. Patients were followed up to three years and assessed for disease recurrence with a history and physical examination every 6 months. RESULTS: A total of 86 patients were included in the study. Of the 86 patients 43 were in SLND group and 43 were in the ALND group. In SLND group 40 (93%) received radiation therapy and in ALND group 41 (95%). No difference was noted in the groups in the use of high tangents, nodal irradiation, or no irradiation. Adjuvant systemic therapy was given to 42 (98%) in SLND group and 42 to (98%) ALND group. CONCLUSION: Radiation therapy has an integral role in the management of breast cancer. In SLND group three years disease free survival was 41 (95%) and for ALND group 40(93%). KEYWORDS: AJND, SLND, Breast Cancer and Radiotherapy.

Sign in / Sign up

Export Citation Format

Share Document